Work

POSTER: IBCL-740: Anchored Matching-Adjusted Indirect Comparison of Epcoritamab, Lenalidomide, and Rituximab vs Tafasitamab, Lenalidomide, and Rituximab in Relapsed/Refractory Follicular Lymphoma: EPCORE FL-1 vs inMIND

Year: 2026

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)01197-3

Authors: Kim M Linton, Moshe Yair Levy, Dai Maruyama, Abel Costa, Shane Gangatharan, Habte Yimer, Abualbishr Alshreef, Wenying Quan, Viktor Chirikov, Gauri Sunkersett, JP Mei, Anthony Wang, Savreet Bains Chawla, Laura Liao, Felipe Marques Goncalves, Zhijie Ding, Marcel Nijland

Institutions: University of Manchester, The Christie NHS Foundation Trust, Cancer Research UK Manchester Centre, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, D’Or Institute for Research and Education, Fiona Stanley Hospital, AbbVie (United States), Genmab (United States), University Medical Center Groningen, University of Groningen

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204696063

FWCI:

Cites:

Cited by:

Related to: 10